Frazier Life Sciences Management, L.P. 13F holdings, Q3 2025
Holdings as of September 30, 2025 · filings on SEC EDGAR · latest filing →
Frazier Life Sciences Management, L.P. disclosed 47 US equity positions worth $3.3bn in its Q3 2025 13F filing. The largest position was MIRM at 14.9% of the reported book, followed by NEWAMSTERDAM PHARMA COMPANY and VRNA. Against the Q2 2025 filing, it opened 4 new positions, added to 10 and reduced 6 among the top 47 holdings.
What did Frazier Life Sciences Management, L.P. own in Q3 2025? Top 47 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2025 |
|---|---|---|---|---|---|---|---|
| 1 | MIRM MIRUM PHARMACEUTICALS INC | Healthcare | 14.9% | $498.2m | 6,795,121 | 0% | held |
| 2 | NEWAMSTERDAM PHARMA COMPANY | 14.2% | $475.0m | 16,701,956 | 1% | added | |
| 3 | VRNA VERONA PHARMA PLC | 10.8% | $361.1m | 3,383,950 | 0% | held | |
| 4 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 6.0% | $199.7m | 3,845,457 | 1% | added |
| 5 | ARQT ARCUTIS BIOTHERAPEUTICS INC | Healthcare | 5.6% | $186.1m | 9,874,511 | 0% | held |
| 6 | PHAT PHATHOM PHARMACEUTICALS INC | 4.4% | $146.7m | 12,466,489 | 0% | held | |
| 7 | KRYS KRYSTAL BIOTECH INC | Healthcare | 3.6% | $121.5m | 688,460 | 0% | held |
| 8 | MAZE MAZE THERAPEUTICS INC | 3.5% | $118.4m | 4,567,274 | -0% | held | |
| 9 | MBX MBX BIOSCIENCES INC | Healthcare | 3.5% | $116.4m | 6,652,013 | 11% | added |
| 10 | IRON DISC MEDICINE INC | Healthcare | 2.8% | $95.1m | 1,438,534 | -13% | reduced |
| 11 | TRVI TREVI THERAPEUTICS INC | Healthcare | 2.8% | $93.9m | 10,259,409 | 0% | held |
| 12 | TARS TARSUS PHARMACEUTICALS INC | Healthcare | 2.1% | $69.4m | 1,167,527 | -16% | reduced |
| 13 | 4XC1 KALVISTA PHARMACEUTICALS INC | 1.8% | $61.4m | 5,039,867 | 3% | added | |
| 14 | ZLAB ZAI LAB LTD | Healthcare | 1.7% | $55.1m | 1,627,320 | 24% | added |
| 15 | AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 1.5% | $51.4m | 1,279,754 | 0% | held |
| 16 | ERAS ERASCA INC | Healthcare | 1.5% | $49.6m | 22,729,436 | 0% | held |
| 17 | CYTK CYTOKINETICS INC | Healthcare | 1.5% | $48.9m | 890,445 | 61% | added |
| 18 | RVMD REVOLUTION MEDICINES INC | Healthcare | 1.4% | $46.6m | 997,455 | 0% | held |
| 19 | PVLA PALVELLA THERAPEUTICS INC NE | 1.4% | $45.3m | 722,400 | 0% | held | |
| 20 | SVRA SAVARA INC | Healthcare | 1.2% | $40.9m | 11,462,301 | 0% | held |
| 21 | DYN DYNE THERAPEUTICS INC | Healthcare | 1.0% | $34.4m | 2,718,105 | 80% | added |
| 22 | ABVX ABIVAX SA | 1.0% | $32.1m | 378,300 | – | new | |
| 23 | AURA AURA BIOSCIENCES INC | 0.9% | $31.5m | 5,100,000 | 0% | held | |
| 24 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 0.9% | $29.6m | 983,715 | 0% | held |
| 25 | LXEO LEXEO THERAPEUTICS INC | Healthcare | 0.9% | $29.4m | 4,424,725 | 0% | held |
| 26 | VALNEVA SE | 0.8% | $28.0m | 2,291,666 | 57% | added | |
| 27 | RNAGBP AVIDITY BIOSCIENCES INC | 0.8% | $27.2m | 625,000 | 0% | held | |
| 28 | ASND ASCENDIS PHARMA A/S | Healthcare | 0.8% | $26.5m | 133,333 | 0% | held |
| 29 | ALKS ALKERMES PLC | Healthcare | 0.6% | $21.0m | 700,647 | -30% | reduced |
| 30 | MREO MEREO BIOPHARMA GROUP PLC | Healthcare | 0.6% | $19.4m | 9,440,112 | 0% | held |
| 31 | AKERO THERAPEUTICS INC | 0.5% | $17.4m | 366,784 | 0% | held | |
| 32 | PCVX VAXCYTE INC | Healthcare | 0.5% | $17.1m | 474,405 | 0% | held |
| 33 | EOLS EVOLUS INC | Healthcare | 0.5% | $16.2m | 2,630,665 | 8% | added |
| 34 | DSGN DESIGN THERAPEUTICS INC | Healthcare | 0.4% | $14.7m | 1,953,547 | 0% | held |
| 35 | IMCR IMMUNOCORE HLDGS PLC | Healthcare | 0.4% | $14.0m | 384,782 | 0% | held |
| 36 | ACAD ACADIA PHARMACEUTICALS INC | Healthcare | 0.4% | $13.1m | 613,837 | – | new |
| 37 | JBIO JADE BIOSCIENCES INC | 0.4% | $12.2m | 1,413,280 | -20% | reduced | |
| 38 | ASMB ASSEMBLY BIOSCIENCES INC | Healthcare | 0.3% | $11.7m | 456,249 | – | new |
| 39 | AVU0 ADVERUM BIOTECHNOLOGIES INC | 0.3% | $9.4m | 2,077,431 | 94% | added | |
| 40 | TVTX TRAVERE THERAPEUTICS INC | Healthcare | 0.3% | $9.4m | 392,092 | -61% | reduced |
| 41 | NEWAMSTERDAM PHARMA COMPANY | 0.3% | $8.6m | 500,333 | 0% | held | |
| 42 | ENGENE HOLDINGS INC | 0.2% | $7.9m | 1,157,380 | – | new | |
| 43 | AUTL AUTOLUS THERAPEUTICS PLC | Healthcare | 0.2% | $7.5m | 4,623,324 | 0% | held |
| 44 | MGNX MACROGENICS INC | Healthcare | 0.2% | $5.3m | 3,175,665 | 0% | held |
| 45 | SLN SILENCE THERAPEUTICS PLC | 0.2% | $5.0m | 970,130 | 0% | held | |
| 46 | ALLO ALLOGENE THERAPEUTICS INC | Healthcare | 0.1% | $4.8m | 3,868,750 | 0% | held |
| 47 | CBIO CRESCENT BIOPHARMA INC. | 0.1% | $3.2m | 272,951 | -40% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.